Histone H3 Lysine 4 and 27 Trimethylation Landscape of Human Alzheimer's Disease

Cells. 2022 Feb 19;11(4):734. doi: 10.3390/cells11040734.

Abstract

Background: Epigenetic remodeling is emerging as a critical process for both the onset and progression of Alzheimer's disease (AD), the most common form of neurodegenerative dementia. However, it is not clear to what extent the distribution of histone modifications is involved in AD.

Methods: To investigate histone H3 modifications in AD, we compared the genome-wide distributions of H3K4me3 and H3K27me3 in entorhinal cortices from severe sporadic AD patients and from age-matched healthy individuals of both sexes.

Results: AD samples were characterized by typical average levels and distributions of the H3K4me3 and H3K27me3 signals. However, AD patients showed a lower H3K4me3 and higher H3K27me3 signal, particularly in males. Interestingly, the genomic sites found differentially trimethylated at the H3K4 between healthy and AD samples involve promoter regions of genes belonging to AD-related pathways such as glutamate receptor signaling.

Conclusions: The signatures of H3K4me3 and H3K27me3 identified in AD patients validate the role of epigenetic chromatin remodeling in neurodegenerative disease and shed light on the genomic adaptive mechanisms involved in AD.

Keywords: Alzheimer’s disease; chromatin; histone modifications; neuronal functions.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / genetics
  • Epigenesis, Genetic
  • Female
  • Histones / metabolism
  • Humans
  • Lysine / metabolism
  • Male
  • Methylation
  • Neurodegenerative Diseases* / genetics
  • Promoter Regions, Genetic

Substances

  • Histones
  • Lysine